AbbVie, Tandem Diabetes Care and Amgen are targeting aging-related healthcare growth through advance

NORTH CHICAGO, Ill., Aug. 31, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wells

Abacus FCF Advisors LLC purchased a new stake in shares of AbbVie Inc. (NYSE: ABBV) in the undefined

Csenge Advisory Group acquired a new position in AbbVie Inc. (NYSE: ABBV) in the second quarter, acc

CM Wealth Advisors LLC purchased a new stake in shares of AbbVie Inc. (NYSE: ABBV) in the second qua

DCF Advisers LLC acquired a new stake in shares of AbbVie Inc. (NYSE: ABBV) in the second quarter, a

Asahi Life Asset Management CO. LTD. bought a new position in AbbVie Inc. (NYSE: ABBV) during the un

AssuredPartners Investment Advisors LLC purchased a new position in AbbVie Inc. (NYSE: ABBV) in the

August Group Capital Ltd purchased a new position in shares of AbbVie Inc. (NYSE: ABBV) in the secon

Great Lakes Advisors LLC bought a new stake in AbbVie Inc. (NYSE: ABBV) during the second quarter, a

Danske Bank A S acquired a new position in AbbVie Inc. (NYSE: ABBV) in the undefined quarter, accord

Compass Wealth Management LLC purchased a new stake in shares of AbbVie Inc. (NYSE: ABBV) during the

Danica Pension Livsforsikringsaktieselskab acquired a new position in shares of AbbVie Inc. (NYSE: A

Gables Capital Management Inc. acquired a new stake in AbbVie Inc. (NYSE: ABBV) in the second quarte

Burke and Herbert Bank and Trust Co. reduced its position in AbbVie Inc. (NYSE: ABBV) by 12.0% durin

Empirical Asset Management LLC acquired a new position in AbbVie Inc. (NYSE: ABBV) in the second qua

Chancellor Financial Group WB LP acquired a new position in AbbVie Inc. (NYSE: ABBV) during the seco

Great Lakes Advisors LLC bought a new position in AbbVie Inc. (NYSE: ABBV) during the second quarter

BOK Financial Private Wealth Inc. acquired a new position in AbbVie Inc. (NYSE: ABBV) in the undefin

AbbVie continues to expand its immunology and neuroscience portfolio through strategic acquisitions.

AbbVie continues to expand its portfolio in high-growth areas like immunology and neuroscience. John

ABBV seeks EU approval for a subcutaneous Skyrizi induction option in Crohn's disease, potentially a

Beverly Hills Private Wealth LLC lowered its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 50.6%

Building a monthly income stream from quarterly dividend payers requires just a little scheduling. T

FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market an

Sticky inflation is quietly rewarding a specific group of stocks with decades of uninterrupted divid

Submission supported by data from Phase 3 pivotal AFFIRM studyIf approved, adult Crohn's disease

Submission supported by data from Phase 3 pivotal AFFIRM study If approved, adult Crohn's disease pa

AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years by 1.74% on an annualized basi

VanEck's concentrated 26-stock portfolio has outpaced Fidelity's broader 334-holding fund over five

AbbVie's oncology sales fall 2.4% in Q2 as Imbruvica declines, while Venclexta and newer drugs help

Lilly and AbbVie bring different growth drivers, pipelines and risks to the table. See which drugmak

Donaldson Capital Management LLC raised its stake in AbbVie Inc. (NYSE: ABBV) by 0.7% in the undefin

Convergence Financial LLC grew its position in AbbVie Inc. (NYSE: ABBV) by 91.7% during the undefine

AbbVie continues to deliver robust top-line and EPS growth, with Skyrizi and Rinvoq strength offsett

AbbVie and Abbott stand out as strong healthcare investments because they combine established busine

AbbVie (NYSE:ABBV) today announced new data highlighting research programs across its lung cancer po

Piper Sandler analyst David Amsellem maintains AbbVie (NYSE:ABBV) with a Overweight and raises th

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Wells Fargo analyst Mohit Bansal maintains AbbVie (NYSE:ABBV) with a Overweight and raises the pr

Wolfe Research analyst Alexandria Hammond upgrades AbbVie (NYSE:ABBV) from Peer Perform to Outper

BNP Paribas analyst Navann Ty maintains AbbVie (NYSE:ABBV) with a Neutral and raises the price ta

Evercore ISI Group analyst Gavin Clark-Gartner maintains AbbVie (NYSE:ABBV) with a Outperform and

Apogee Therapeutics (NASDAQ:APGE) reported quarterly losses of $(1.14) per share which missed the an

Kathy Hochul says Trump's Medicare subsidy decision will raise prescription drug costs for 1.3 m

Allergan Aesthetics, an AbbVie company (NYSE:ABBV), today announced the U.S. Food and Drug Administr

Guggenheim analyst Vamil Divan maintains AbbVie (NYSE:ABBV) with a Buy and raises the price targe

UBRELVY® (ubrogepant) positive recommendation by Canada's Drug Agency (CDA-AMC) is supported by

Canaccord Genuity analyst Gary Nachman maintains AbbVie (NYSE:ABBV) with a Buy and raises the pri

AstraZeneca and Bristol Myers reportedly discuss a $400 billion merger as analyst assesses valuation